Mitochondria Could Be a Target for Therapeutic Strategy for Alzheimer’s Disease Patients

A study in the Sept. 21 on-line edition of Nature Medicine describes the function and interaction of a **critical molecule** involved in cell death in **Alzheimer’s disease** patients. These new findings reveal that blocking this molecule, called **Cyclophilin D** (CypD), and development of surrounding mitochondrial targets may be viable **therapeutic strategies** for the prevention and treatment of Alzheimer’s disease, according to Shi Du Yan, Ph.D., professor of clinical pathology in the Department's of Pathology and Surgery and in the Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University Medical Center, who led the multi-center research. "Columbia University Medical Center":[ http://www.cumc.columbia.edu/news/press_releases/mitochondria-alzheimer-cyclophilin-d-cypd.html]

---